Physician-pharmacist collaborative practice and telehealth may transform hypertension management.
Journal
Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
06
10
2018
accepted:
03
12
2018
pubmed:
14
12
2018
medline:
27
6
2020
entrez:
15
12
2018
Statut:
ppublish
Résumé
Community pharmacists play a crucial role in hypertension management and their intervention, mainly including education, medication monitoring, and reviewing, blood pressure (BP) measurement and cardiovascular risk factors tracking, have proved to enhance BP control and adherence to antihypertensive treatment. A multidisciplinary collaborative approach with the referring physician and a patient-centered model of care have been proved to be particularly effective for improving control of hypertension and promoting patients' health. The inclusion of telehealth in such model (the so-called telepharmacy) may expand the reach of the pharmacist's intervention and provide pharmacy operations and patient care at a distance with further benefits for hypertensive patients and their managing physicians. Very few randomized controlled studies have evaluated the clinical efficacy of the implementation of telepharmacy services in the management of hypertension, with the strongest evidence limited to physician-pharmacist collaborative interventions based on home BP telemonitoring plus patient education on lifestyle, drug therapy, and cardiovascular risk factors control. The results of these trials documented a benefit of telehealth mainly in terms of improvement of BP control consequent to antihypertensive medication intensification and optimization. Although promising, these results need to be corroborated through larger, prospective, and long-term studies, which should also evaluate additional long-term benefits of telepharmacy services in hypertension management.
Identifiants
pubmed: 30546052
doi: 10.1038/s41371-018-0147-x
pii: 10.1038/s41371-018-0147-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
177-187Références
Di Palo KE, Kish T. The role of the pharmacist in hypertension management. Curr Opin Cardiol. 2018;33:382–7.
pubmed: 29697544
doi: 10.1097/HCO.0000000000000527
Proia KK, Thota AB, Njie GJ, Finnie RK, Hopkins DP, Mukhtar Q, et al. Community Preventive Services Task Force. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86–99.
pubmed: 24933494
pmcid: 4672378
doi: 10.1016/j.amepre.2014.03.004
Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748–55.
pubmed: 19858431
pmcid: 2882164
Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther. 2015;13:209–21.
pubmed: 25578090
doi: 10.1586/14779072.2015.1001368
World Health Organization (WHO). Pharmacy-based hypertension management model: protocol and guidelines. A joint CINDI/EuroPharm Forum Project. 2005. Available at http://apps.who.int/iris/bitstream/10665/107638/1/E85730.pdf (last accessed 3 October2018).
Albasri A, Prinjha S, McManus RJ, Sheppard JP. Hypertension referrals from community pharmacy to general practice: multivariate logistic regression analysis of 131 419 patients. Br J Gen Pract. 2018;68:e541–e550.
pubmed: 29970396
pmcid: 6058643
doi: 10.3399/bjgp18X697925
O’Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15:23–38.
doi: 10.1097/MBP.0b013e3283360e98
pubmed: 20110786
Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type. American National Standards. ANSI/AAMI/ISO 81060-2:2013. Available at http://my.aami.org/aamiresources/previewfiles/8106002_1306_preview.pdf (last accessed 3 October 2018).
Erdem DG, Erdem E, Dilek M, Aydogdu T, Selim N, Demiray F, et al. Accuracy of sphygmomanometers at pharmacies. Kidney Blood Press Res. 2009;32:231–4.
pubmed: 19622898
doi: 10.1159/000228936
Gonzalvo J, Zillich A. Accuracy of automated community pharmacy-based blood pressure devices. J Am Pharm Assoc. 2003;2011:408–11.
Ross KL, Bhasin S, Wilson MP, Stewart SA, Wilson TW. Accuracy of drug store blood pressure monitors: an observational study. Blood Press Monit. 2013;18:339–41.
pubmed: 24192848
doi: 10.1097/MBP.0000000000000003
Hodgkinson J, Koshiaris C, Martin U, Mant J, Heneghan C, Hobbs FR, et al. Accuracy of monitors used for blood pressure checks in English retail pharmacies: a cross-sectional observational study. Br J Gen Pract. 2016;66:e309–314.
pubmed: 27025555
pmcid: 4838442
doi: 10.3399/bjgp16X684769
Sabater-Hernández D, de la Sierra A, Sánchez-Villegas P, Baena MI, Amariles P, Faus MJ, MEPAFAR study workgroup. Magnitude of the white-coat effect in the community pharmacy setting: the MEPAFAR study. Am J Hypertens. 2011;24:887–92.
pubmed: 21509052
doi: 10.1038/ajh.2011.68
Sabater-Hernández D, De La Sierra A, Sánchez-Villegas P, Santana-Pérez FM, Merino-Barber L, Faus MJ, MEPAFAR Study Workgroup. Agreement between community pharmacy and ambulatory and home blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study. J Clin Hypertens (Greenwich). 2012;14:236–44.
doi: 10.1111/j.1751-7176.2012.00598.x
Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá Á, Martínez-Martínez F. Agreement between community pharmacy, physician’s office, and home blood pressure measurement methods: the PALMERA Study. Am J Hypertens. 2012;25:290–6.
pubmed: 22089107
doi: 10.1038/ajh.2011.207
Albasri A, OʼSullivan JW, Roberts NW, Prinjha S, McManus RJ, Sheppard JP. A comparison of blood pressure in community pharmacies with ambulatory, home and general practitioner office readings: systematic review and meta-analysis. J Hypertens. 2017;35:1919–28.
pubmed: 28594707
pmcid: 5585128
doi: 10.1097/HJH.0000000000001443
Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770–81.
pubmed: 17925496
doi: 10.1345/aph.1K311
Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. Am J Health Syst Pharm. 2011;68:241–53.
pubmed: 21258029
doi: 10.2146/ajhp090656
Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718.
pubmed: 24721801
pmcid: 4187511
doi: 10.1161/JAHA.113.000718
Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78:1238–47.
pubmed: 24966032
pmcid: 4256613
doi: 10.1111/bcp.12452
Rotta I, Souza TT, Salgado TM, Correr CJ, Fernandez-Llimos F. Characterization of published randomized controlled trials assessing clinical pharmacy services around the world. Res Soc Adm Pharm. 2017;13:201–8.
doi: 10.1016/j.sapharm.2016.01.003
Kennelty KA, Polgreen LA, Carter BL. Team-based care with pharmacists to improve blood pressure: a review of recent literature. Curr Hypertens Rep. 2018;20:1.
pubmed: 29349522
pmcid: 5991484
doi: 10.1007/s11906-018-0803-0
Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N, Goedken AM, Chrischilles EA, Carter BL. Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens. 2017;35:178–87.
pubmed: 27684354
doi: 10.1097/HJH.0000000000001126
Schell SF, Luke DA, Schooley MW, Elliott MB, Herbers SH, Mueller NB, et al. Public health program capacity for sustainability: a new framework. Implement Sci. 2013;8:15.
pubmed: 23375082
pmcid: 3599102
doi: 10.1186/1748-5908-8-15
Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page RL 2nd, et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66:2129–39.
pubmed: 26541925
doi: 10.1016/j.jacc.2015.09.025
Al Hamarneh YN, Houle SK, Padwal R, Tsuyuki RT. Hypertension Canada’s 2016 Canadian Hypertension Education Program guidelines for pharmacists: an update. Can Pharm J. 2016;149:337–44.
doi: 10.1177/1715163516671747
Haines SL, DeHart RM, Hess KM, Marciniak MW, Mount JK, Phillips BB, et al. Report of the 2009-2010 Professional Affairs Committee: pharmacist integration in primary care and the role of academic pharmacy. Am J Pharm Educ. 2010;74:S5.
pubmed: 21436914
pmcid: 3058453
doi: 10.5688/aj7410S5
Sabater-Hernández D, de la Sierra A, Bellver-Monzó O, Divisón JA, Gorostidi M, Perseguer-Torregosa Z, et al. Guía de actuación para el farmacéutico comunitario en pacientes con hipertensión arterial y riesgo cardiovascular. Documento de consenso (versión resumida). Hypertensión. 2011;28:169–81.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in adults. Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–324.
pubmed: 29133354
doi: 10.1161/HYP.0000000000000066
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.
pubmed: 30234752
doi: 10.1097/HJH.0000000000001940
Omboni S, Tenti M. Telepharmacy for the management of cardiovascular patients in the community. Trends Cardiovasc Med 2018;pii: S1050-1738:30131-2.
Abughosh S, Wang X, Serna O, Esse T, Mann A, Masilamani S, et al. A motivational interviewing intervention by pharmacy students to improve medication adherence. J Manag Care Spec Pharm. 2017;23:549–60.
pubmed: 28448784
Milani RV, Lavie CJ, Bober RM, Milani AR, Ventura HO. Improving hypertension control and patient engagement using digital tools. Am J Med. 2017;130:14–20.
pubmed: 27591179
doi: 10.1016/j.amjmed.2016.07.029
Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, et al. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011;17:e96–103.
pubmed: 21774100
Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310:46–56.
pubmed: 23821088
pmcid: 4311883
doi: 10.1001/jama.2013.6549
Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013;6:157–63.
pubmed: 23463811
doi: 10.1161/CIRCOUTCOMES.112.968172
Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857–67.
pubmed: 18577730
pmcid: 2715866
doi: 10.1001/jama.299.24.2857
Welch LK, Olson KL, Snow KE, Pointer L, Lambert-Kerzner A, Havranek EP, et al. Systolic blood pressure control after participation in a hypertension intervention study. Am J Manag Care. 2011;17:473–8.
pubmed: 21819167
Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, et al. Long-hypertension control and patient engagement using digital term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension. follow-up of a cluster randomized clinical trial. JAMA Netw Open. 2018;1:e181617.
pubmed: 30646139
pmcid: 6324502
doi: 10.1001/jamanetworkopen.2018.1617
Green BB, Anderson ML, Ralston JD, Catz SL, Cook AJ. Blood pressure 1 year after completion of web-based pharmacist care. JAMA Intern Med. 2013;173:1250–2.
pubmed: 23689927
pmcid: 3938109
doi: 10.1001/jamainternmed.2013.1037
Fishman PA, Cook AJ, Anderson ML, Ralston JD, Catz SL, Carrell D, et al. Improving BP control through electronic communications: an economic evaluation. Am J Manag Care. 2013;19:709–16.
pubmed: 24304254
pmcid: 3938103
Billups SJ, Moore LR, Olson KL, Magid DJ. Cost-effectiveness evaluation of a home blood pressure monitoring program. Am J Manag Care. 2014;20:e380–7.
Dehmer SP, Maciosek MV, Trower NK, Asche SE, Bergdall AR, Nyboer RA, et al. Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial. J Am Coll Clin Pharm. 2018;1:21–30.
pubmed: 30320302
pmcid: 6181443
doi: 10.1002/jac5.1001
Robins LS, Jackson JE, Green BB, Korngiebel D, Force RW, Baldwin LM. Barriers and facilitators to evidence-based blood pressure control in community practice. J Am Board Fam Med. 2013;26:539–57.
pubmed: 24004706
doi: 10.3122/jabfm.2013.05.130060
Kerby TJ, Asche SE, Maciosek MV, O’Connor PJ, Sperl-Hillen JM, Margolis KL. Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial. J Clin Hypertens (Greenwich). 2012;14:668–74.
doi: 10.1111/j.1751-7176.2012.00685.x
Asche SE, O’Connor PJ, Dehmer SP, Green BB, Bergdall AR, Maciosek MV, et al. Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management. J Am Soc Hypertens. 2016;10:873–80.
pubmed: 27720142
pmcid: 5107124
doi: 10.1016/j.jash.2016.09.004